BMMay 17, 2021
Understanding the Performance of Knowledge Graph Embeddings in Drug DiscoveryStephen Bonner, Ian P Barrett, Cheng Ye et al.
Knowledge Graphs (KG) and associated Knowledge Graph Embedding (KGE) models have recently begun to be explored in the context of drug discovery and have the potential to assist in key challenges such as target identification. In the drug discovery domain, KGs can be employed as part of a process which can result in lab-based experiments being performed, or impact on other decisions, incurring significant time and financial costs and most importantly, ultimately influencing patient healthcare. For KGE models to have impact in this domain, a better understanding of not only of performance, but also the various factors which determine it, is required. In this study we investigate, over the course of many thousands of experiments, the predictive performance of five KGE models on two public drug discovery-oriented KGs. Our goal is not to focus on the best overall model or configuration, instead we take a deeper look at how performance can be affected by changes in the training setup, choice of hyperparameters, model parameter initialisation seed and different splits of the datasets. Our results highlight that these factors have significant impact on performance and can even affect the ranking of models. Indeed these factors should be reported along with model architectures to ensure complete reproducibility and fair comparisons of future work, and we argue this is critical for the acceptance of use, and impact of KGEs in a biomedical setting.
AIFeb 19, 2021
A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph PerspectiveStephen Bonner, Ian P Barrett, Cheng Ye et al.
Drug discovery and development is a complex and costly process. Machine learning approaches are being investigated to help improve the effectiveness and speed of multiple stages of the drug discovery pipeline. Of these, those that use Knowledge Graphs (KG) have promise in many tasks, including drug repurposing, drug toxicity prediction and target gene-disease prioritisation. In a drug discovery KG, crucial elements including genes, diseases and drugs are represented as entities, whilst relationships between them indicate an interaction. However, to construct high-quality KGs, suitable data is required. In this review, we detail publicly available sources suitable for use in constructing drug discovery focused KGs. We aim to help guide machine learning and KG practitioners who are interested in applying new techniques to the drug discovery field, but who may be unfamiliar with the relevant data sources. The datasets are selected via strict criteria, categorised according to the primary type of information contained within and are considered based upon what information could be extracted to build a KG. We then present a comparative analysis of existing public drug discovery KGs and a evaluation of selected motivating case studies from the literature. Additionally, we raise numerous and unique challenges and issues associated with the domain and its datasets, whilst also highlighting key future research directions. We hope this review will motivate KGs use in solving key and emerging questions in the drug discovery domain.
CLJan 2, 2021
End-to-End Training of Neural Retrievers for Open-Domain Question AnsweringDevendra Singh Sachan, Mostofa Patwary, Mohammad Shoeybi et al.
Recent work on training neural retrievers for open-domain question answering (OpenQA) has employed both supervised and unsupervised approaches. However, it remains unclear how unsupervised and supervised methods can be used most effectively for neural retrievers. In this work, we systematically study retriever pre-training. We first propose an approach of unsupervised pre-training with the Inverse Cloze Task and masked salient spans, followed by supervised finetuning using question-context pairs. This approach leads to absolute gains of 2+ points over the previous best result in the top-20 retrieval accuracy on Natural Questions and TriviaQA datasets. We also explore two approaches for end-to-end supervised training of the reader and retriever components in OpenQA models. In the first approach, the reader considers each retrieved document separately while in the second approach, the reader considers all the retrieved documents together. Our experiments demonstrate the effectiveness of these approaches as we obtain new state-of-the-art results. On the Natural Questions dataset, we obtain a top-20 retrieval accuracy of 84, an improvement of 5 points over the recent DPR model. In addition, we achieve good results on answer extraction, outperforming recent models like REALM and RAG by 3+ points. We further scale up end-to-end training to large models and show consistent gains in performance over smaller models.